These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37641637)

  • 1. Active surveillance of adverse events following COVID-19 vaccines in a tertiary care hospital.
    Cherian NM; Durai DA; Jaisel M; Sharma D; Sebastian J; Basavaraja CK; Mathew M
    Ther Adv Vaccines Immunother; 2023; 11():25151355231193975. PubMed ID: 37641637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse events following COVID-19 vaccination: first 90 days of experience from a tertiary care teaching hospital in South India.
    Basavaraja CK; Sebastian J; Ravi MD; John SB
    Ther Adv Vaccines Immunother; 2021; 9():25151355211055833. PubMed ID: 34841193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study.
    Sebastian J; Gurumurthy P; Ravi MD; Ramesh M
    Ther Adv Vaccines Immunother; 2019; 7():2515135519889000. PubMed ID: 31799496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse Events Following COVID-19 Vaccination in Selected Apartments in Bangalore, India.
    Chakraborty A; Reval N; Kamath L
    Cureus; 2022 Feb; 14(2):e21809. PubMed ID: 35291520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Prospective Observational Study on BBV152 Coronavirus Vaccine Use in Adolescents and Comparison with Adults: Interim Results of the First Real-World Safety Analysis.
    Kaur U; K L A; Chauhan M; Joshi A; Das A; Kansal S; Jaisawal V; Patwardhan K; Chakrabarti SS
    Drug Saf; 2022 Oct; 45(10):1099-1109. PubMed ID: 36030299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serious adverse event following immunization and thromboembolic events associated with COVID19 vaccination: An analysis of nationwide causality assessment from India.
    Gandhi AP; Venkatesh U; Murali N
    Indian Heart J; 2023; 75(2):139-144. PubMed ID: 36863611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic causality assessment of adverse events following HPV vaccines: Analysis of current data from Apulia region (Italy).
    Tafuri S; Fortunato F; Gallone MS; Stefanizzi P; Calabrese G; Boccalini S; Martinelli D; Prato R
    Vaccine; 2018 Feb; 36(8):1072-1077. PubMed ID: 29358055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of Frequencies of Reported Adverse Events Following Immunization Among Four Different COVID-19 Vaccine Brands.
    Kant A; Jansen J; van Balveren L; van Hunsel F
    Drug Saf; 2022 Apr; 45(4):319-331. PubMed ID: 35314943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety Profile of Recommended Vaccinations in Adolescents: Data from Surveillance of Adverse Events Following Immunization in Puglia (Italy), 2016-2020.
    Di Lorenzo A; Bianchi FP; Martinelli A; Lattanzio S; Carbonara A; Diella G; Tafuri S; Stefanizzi P
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse events following measles-mumps-rubella-varicella vaccine: an independent perspective on Italian pharmacovigilance data.
    Bellavite P; Donzelli A
    F1000Res; 2020; 9():1176. PubMed ID: 33335717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience.
    Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML
    Expert Rev Vaccines; 2018 Jun; 17(6):555-562. PubMed ID: 29865876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine safety surveillance in Canada: Reports to CAEFISS, 2017.
    Johnson K; Anyoti H; Coulby C
    Can Commun Dis Rep; 2018 Dec; 44(12):324-330. PubMed ID: 31517950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-Marketing Active Surveillance of Adverse Reactions Following Influenza Cell-Based Quadrivalent Vaccine: An Italian Prospective Observational Study.
    Stefanizzi P; De Nitto S; Spinelli G; Lattanzio S; Stella P; Ancona D; Dell'Aera M; Padovano M; Soldano S; Tafuri S; Bianchi FP
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34064483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneously reported adverse events following COVID-19 basic and booster immunizations in the Netherlands.
    van der Boor SC; Schmitz-de Vries ETJ; Smits D; Scholl JHG; Rolfes L; van Hunsel F
    Vaccine; 2023 Jun; 41(29):4319-4326. PubMed ID: 37286408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of adverse events following immunization with measles rubella vaccine at a tertiary care hospital in East Delhi, India.
    Bhowmik E; Singh A; Sachan R
    Ther Adv Vaccines Immunother; 2020; 8():2515135520940131. PubMed ID: 32685913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine safety surveillance in Canada: Reports to CAEFISS, 2013-2016.
    Ahmadipour N; Watkins K; Fréchette M; Coulby C; Anyoti H; Johnson K
    Can Commun Dis Rep; 2018 Sep; 44(9):206-214. PubMed ID: 31015811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety profile of MenB-FHBp vaccine among adolescents: data from surveillance of Adverse Events Following Immunization in Puglia (Italy), 2018-2020.
    Stefanizzi P; Bianchi FP; Martinelli A; Di Lorenzo A; De Petro P; Graziano G; Lattanzio S; Diella G; Stella P; Ancona D; Tafuri S
    Hum Vaccin Immunother; 2022 Dec; 18(1):2041359. PubMed ID: 35201942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and types of adverse events during mass vaccination campaign with the meningococcal a conjugate vaccine (MENAFRIVAC™) in Cameroon.
    Ateudjieu J; Stoll B; Nguefack-Tsague G; Yakum MN; Mengouo MN; Genton B
    Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1170-1178. PubMed ID: 27174237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Pattern and Severity of Adverse Events Following Immunization (AEFIs) Associated With Chadox1 nCOV-19 Corona Virus Vaccine (Recombinant) Among the Healthcare Workers of a Tertiary Care Institute of Eastern Uttar Pradesh, India.
    Kamble B; Bashar MA; Mishra CP
    Cureus; 2022 Feb; 14(2):e21848. PubMed ID: 35273834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Population-Based Structures to Actively Monitor AEFIs during a Mass Immunization Campaign-A Case of Measles-Rubella and Polio Vaccines.
    Kajungu D; Nambasa V; Muhoozi M; Tusabe J; Kampmann B; Todd J
    Vaccines (Basel); 2021 Nov; 9(11):. PubMed ID: 34835224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.